logo
  Join        Login             Stock Quote

Orasure Technologies (OSUR): Advisory Committee To Review Orasure OTC Rapid HIV Test On May 15

 April 04, 2012 12:21 PM
 


OraSure Technologies Inc. (NASDAQ:OSUR) said the U.S. Food and Drug Administration (FDA) set May 15 date for Blood Products Advisory Committee (BPAC) review of OraSure over-the-counter rapid HIV-1/2 test.

The advisory committee would consider the company's application for the approval of its OraQuick Rapid HIV-1/2 test, which is an over-the-counter version of the OraQuick ADVANCE  product currently sold into the professional market.

Chief Executive Douglas Michels believes that the availability of an easy-to-use, accurate in-home HIV test will enable more people to learn their presumptive HIV status so that they can receive necessary care and support.

[Related -iStock Picks: The Courage To Look Back]

The company said it would be presenting the findings from the final phase of clinical testing, which involved the use of the OraQuick In-Home HIV Test, an OTC investigational use version of the OraQuick ADVANCE Rapid HIV-1/2 test, by individuals in an unobserved setting.

About 5,800 subjects were enrolled and tested in this phase across 20 sites nationwide, resulting in the identification of more than 100 previously undiagnosed individuals with HIV.

OraSure currently manufactures and sells the OraQuick ADVANCE Rapid HIV-1/2 Test which is the first and only FDA-approved and CLIA-waived rapid point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in oral fluid in 20 minutes.

As the market leading rapid HIV test with over 20 million tests sold, OraQuick ADVANCE is used extensively throughout the United States in public health settings, hospitals, community-based organizations, and physician offices where HIV testing is conducted.

[Related -Orasure Technologies Inc. (OSUR) Needs To Go Global To Change The Game]

OSUR is trading down 2.27% at $11.21 on Wednesday. The stock has been trading between $6.29 and $11.78 for the past 52 weeks.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageXerox Corp. (XRX): An Insider’s $500,000 Insider Buy

Last week was a healthy week of insider buying as 194 companies reported purchase records. The number read on...

article imageQihoo 360 Technology Co Ltd. (QIHU) Q2 Earnings Preview: A Green Monday

Qihoo 360 Technology Co Ltd. (NYSE:QIHU) will report its second quarter 2014 financial results on Monday, read on...

article imageSix Stocks that Could Outperform in the next 90 days

Earlier today, Goldman Sachs put out its list of the 50 stocks that Matter Most. It’s a list of the 50 read on...

article imageFoot Locker, Inc. (FL) Q2 Earnings Preview: Running Past the Street View

Foot Locker, Inc. (NYSE:FL) plans to report financial results for its second quarter ended August 2, 2014 read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center

Related Articles:

Low Volume, But Volatile Day
More Articles on: Medical



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.